Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses. Their findings can support the design of an inhibitor that can target aggressive cancers.
Scientists at ORNL used neutrons to end a decades-long debate about an enzyme cancer uses. Their findings can support the design of an inhibitor that can target aggressive cancers.
Designed by doctors. Powered by AI.
Owned by you.